The drop represents a return to a more normal pace of openings post-pandemic but likely also reflects the reimbursement and regulatory challenges facing the industry.

Quest will become the exclusive independent national laboratory provider of clinical lab and anatomic pathology services for Sentara members in Florida and Virginia.

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

Last week, readers were most interested in a story about how diagnostic firms may be impacted by the FDA's final rule on laboratory-developed tests.

The firm will use the money to help advance the development of its digital slide image sharing platform, invest in personnel, and reach regulatory milestones.